Compare DexCom, Inc. (DXCM) vs Victoria's Secret & Co (VSXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Victoria's Secret & Co — how do they compare? DexCom, Inc. trades at $84.02 (market cap $31.86B), while Victoria's Secret & Co trades at $82.21 (market cap $6.91B). The key difference: DexCom, Inc. is far larger — about 4.6× Victoria's Secret & Co's market cap, and DexCom, Inc. is more actively traded (3,607,070 versus 1,346,928). Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Victoria's Secret & Co for 34 Days on average.
| DXCM | VSXY | |
|---|---|---|
Market Cap | $31.86B | $6.91B |
Volume | 3,607,070 | 1,346,928 |
Sector | Health | Consumer Cyclical |
52-Week High | $92.34 | $99.97 |
52-Week Low | $54.84 | $28.25 |
Typical Hold Time | 62 Days | 34 Days |
Enterprise Value | $31.32B | $9.29B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $84.3, up 1.09% today, with a bearish technical signal despite strong fundamentals. The company reported Q2 2026 EPS of $0.70, beating estimates, continuing a trend of earnings outperformance. Revenue growth is robust, with 2025 revenue reaching $4.66 billion and net income margin improving to 20.12%. Analyst consensus is strongly bullish with an 80.77% buy rating and a $95.07 price target, suggesting significant upside from current levels.
The outlook for DXCM is positive driven by expansion in continuous glucose monitoring for Type 2 diabetes, as highlighted in recent company reports. Key risks include competitive pressures and reimbursement challenges. With solid cash flow generation and institutional support, the stock presents a growth opportunity, though investors should monitor execution against high expectations.
Victoria's Secret (VSXY) trades at $85.79, up 0.83% with a bullish technical signal and strong earnings beat history. The stock shows robust profitability with 45.27% ROE and 39.57% gross margins, though net margins remain modest at 5.47%. Recent news highlights fashion show expansion and global growth initiatives, with institutional buying supporting positive sentiment. The current price sits near the consensus target of $86.80, with support at $85 and resistance at $87.
VSXY presents a compelling growth story with accelerating fundamentals and analyst support, though rich valuation at 19.33 P/E and competitive retail pressures warrant caution. The 2026 outlook improvement and consistent earnings beats provide upside potential, while margin pressures and consumer spending volatility represent key risks for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Victoria's Secret & Co
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →
